HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ichthyosis bullosa of Siemens: response to topical tazarotene.

Abstract
In 1937, Siemens described a Dutch family with superficial blistering, flexural hyperkeratosis, and characteristic mauserung appearance. Since then, less than 20 kindreds with this condition have been described in the English dermatologic literature. A 14-year-old boy presented with history of recurrent blistering and peeling of skin since the age of 1 month, predominantly seen over limbs and trunk, often associated with secondary infection. His mother also had similar symptoms from childhood. On examination, the child had typical mauserung peeling of the skin and dirty gray hyperkeratosis in a rippled pattern over flexures. Skin biopsy from the boy showed intracorneal blistering with epidermolytic hyperkeratosis in the upper spinous layers. The typical history and clinical features along with characteristic histological findings confirmed our diagnosis of ichthyosis bullosa of Siemens. It must be differentiated from other conditions with epidermolytic hyperkeratosis and skin peeling, such as bullous ichthyosiform erythroderma of Brocq and peeling skin syndrome. Our patient responded well to 0.05% topical tazarotene gel over four weeks.
AuthorsS Rajiv, S V Rakhesh
JournalIndian journal of dermatology, venereology and leprology (Indian J Dermatol Venereol Leprol) 2006 Jan-Feb Vol. 72 Issue 1 Pg. 43-6 ISSN: 0378-6323 [Print] United States
PMID16481710 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Gels
  • Keratolytic Agents
  • Nicotinic Acids
  • tazarotene
Topics
  • Administration, Topical
  • Adolescent
  • Adult
  • Female
  • Gels
  • Humans
  • Hyperkeratosis, Epidermolytic (drug therapy)
  • Keratolytic Agents (administration & dosage, therapeutic use)
  • Male
  • Nicotinic Acids (administration & dosage, therapeutic use)
  • Skin Diseases, Vesiculobullous (drug therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: